Showing results (21-30 of 43) with videos related to
Sort By:
Pageof 5
ACS Omega|July 21, 2020
Phase-Selective and Localized TiO2 Coating on Additive and Wrought Titanium by a Direct Laser Surface Modification ApproachParvin Fathi-Hafshejani, Haden Johnson, Zabihollah Ahmadi, et al.Clinical and Translational Radiation Oncology|January 21, 2020
Treatment of oligometastatic lung cancer with brain metastases using stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT)John Nikitas, Michael Roach, Cliff Robinson, et al.Applied and Environmental Microbiology|January 20, 2019
Inactivating Mutations in Irc7p Are Common in Wine Yeasts, Attenuating Carbon-Sulfur β-Lyase Activity and Volatile Sulfur Compound ProductionAntonio G Cordente, Anthony R Borneman, Caroline Bartel, et al.Practical Radiation Oncology|June 17, 2018
Local control for clinical stage I non-small cell lung cancer treated with 5-fraction stereotactic body radiation therapy is not associated with treatment schedulePamela Samson, Sana Rehman, Aditya Juloori, et al.Practical Radiation Oncology|February 1, 2020
Adherence of US Insurance Payer Policies to the American Society of Radiation Oncology Stereotactic Radiosurgery Model PolicyComron Hassanzadeh, Michael Roach, Keith Rich, et al.Microorganisms|May 28, 2022
The StkSR Two-Component System Influences Colistin Resistance in Acinetobacter baumanniiSarah K Giles, Uwe H Stroeher, Bhavya Papudeshi, et al.Journal of Medical Imaging (Bellingham, Wash.)|September 13, 2017
Adaptive anatomical preservation optimal denoising for radiation therapy daily MRIRapeepan Maitree, Gloria J Guzman Perez-Carrillo, Joshua S Shimony, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 4, 2018
Cardiac dose is associated with immunosuppression and poor survival in locally advanced non-small cell lung cancerJessika A Contreras, Alexander J Lin, Ashley Weiner, et al.Journal of Thoracic Disease|December 7, 2020
Implications of pneumonitis after chemoradiation and durvalumab for locally advanced non-small cell lung cancerComron Hassanzadeh, Timothy Sita, Rohan Savoor, et al.FEBS Letters|June 10, 2025
Validation of single-cell transcriptomic profiles from Illumina and MGI Tech sequencing platformsValerie Vandenbempt, Michael Roach, Monika Mohenska, et al.Pageof 5